| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYO1A KIF1A KIF26A CECR2 RNF213 MSH2 ATP10D ACSL1 RUVBL1 STARD9 HELZ2 DHX35 KIFC3 POLQ ATP2A1 ATP2A3 KIF22 | 7.07e-07 | 614 | 148 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.83e-05 | 118 | 148 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF1A KIF26A RNF213 MSH2 ATP10D RUVBL1 HELZ2 DHX35 POLQ ATP2A1 ATP2A3 KIF22 | 1.13e-04 | 441 | 148 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 1.63e-04 | 3 | 148 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 1.63e-04 | 3 | 148 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.72e-04 | 70 | 148 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | calcium-dependent ATPase activity | 3.24e-04 | 4 | 148 | 2 | GO:0030899 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF1A KIF26A RNF213 RHOT2 MSH2 ATP10D EEF2 RUVBL1 HELZ2 SEPTIN1 DHX35 POLQ ATP2A1 ATP2A3 KIF22 | 6.52e-04 | 775 | 148 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | extracellular matrix protein binding | 8.03e-04 | 6 | 148 | 2 | GO:1990430 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 MSH2 PRKDC IGKV1D-37 POLQ IGKV1D-17 IGKV1D-13 IGKV1D-12 | 4.13e-11 | 241 | 155 | 16 | GO:0002377 |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 MSH2 PRKDC IGKV1D-37 POLQ IGKV1D-17 IGKV1D-13 IGKV1D-12 SMAD7 | 1.05e-08 | 403 | 155 | 17 | GO:0002440 |
| GeneOntologyBiologicalProcess | adaptive immune response | IGKV1-37 MYO1G IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 CTSC ICAM1 RELB MSH2 SCART1 C4BPA LOXL3 IGKV1D-37 IGKV1D-17 IGKV1D-13 IGKV1D-12 SMAD7 | 3.24e-07 | 838 | 155 | 22 | GO:0002250 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-37 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 4.60e-10 | 166 | 159 | 13 | GO:0019814 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NPHS1 COL6A2 ADAMTS3 CTSC ICAM1 LAMA3 PAPLN THBS2 CLEC14A ADAMTS17 LOXL3 BCAM ADAMTSL4 | 2.14e-04 | 530 | 159 | 13 | GO:0062023 |
| Domain | Ig_I-set | NPHS1 LRFN1 CADM4 OBSCN OBSL1 PAPLN DSCAML1 NTM MYBPHL MERTK | 2.50e-06 | 190 | 146 | 10 | IPR013098 |
| Domain | I-set | NPHS1 LRFN1 CADM4 OBSCN OBSL1 PAPLN DSCAML1 NTM MYBPHL MERTK | 2.50e-06 | 190 | 146 | 10 | PF07679 |
| Domain | - | NPHS1 EPOR LRFN1 CADM4 ICAM1 ICAM3 OBSCN OBSL1 PAPLN RELB SEMA3G DSCAML1 NTM MYBPHL BCAM MERTK PLXNB3 EPHA5 | 4.36e-06 | 663 | 146 | 18 | 2.60.40.10 |
| Domain | fn3 | 5.21e-06 | 162 | 146 | 9 | PF00041 | |
| Domain | IG | NPHS1 LRFN1 CADM4 ICAM1 ICAM3 OBSCN OBSL1 PAPLN SEMA3G DSCAML1 NTM MYBPHL BCAM MERTK | 5.69e-06 | 421 | 146 | 14 | SM00409 |
| Domain | Ig_sub | NPHS1 LRFN1 CADM4 ICAM1 ICAM3 OBSCN OBSL1 PAPLN SEMA3G DSCAML1 NTM MYBPHL BCAM MERTK | 5.69e-06 | 421 | 146 | 14 | IPR003599 |
| Domain | Ig-like_fold | NPHS1 EPOR LRFN1 CADM4 ICAM1 ICAM3 OBSCN OBSL1 PAPLN RELB SEMA3G DSCAML1 NTM MYBPHL BCAM MERTK PLXNB3 EPHA5 | 1.03e-05 | 706 | 146 | 18 | IPR013783 |
| Domain | PLAC | 1.27e-05 | 19 | 146 | 4 | PS50900 | |
| Domain | PLAC | 1.27e-05 | 19 | 146 | 4 | IPR010909 | |
| Domain | FN3 | 1.52e-05 | 185 | 146 | 9 | SM00060 | |
| Domain | IGc2 | 1.63e-05 | 235 | 146 | 10 | SM00408 | |
| Domain | Ig_sub2 | 1.63e-05 | 235 | 146 | 10 | IPR003598 | |
| Domain | ig | 1.88e-05 | 190 | 146 | 9 | PF00047 | |
| Domain | Immunoglobulin | 1.88e-05 | 190 | 146 | 9 | IPR013151 | |
| Domain | - | 2.32e-05 | 44 | 146 | 5 | 3.40.850.10 | |
| Domain | Kinesin | 2.32e-05 | 44 | 146 | 5 | PF00225 | |
| Domain | KISc | 2.32e-05 | 44 | 146 | 5 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.32e-05 | 44 | 146 | 5 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.32e-05 | 44 | 146 | 5 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.32e-05 | 44 | 146 | 5 | PS50067 | |
| Domain | FN3 | 2.71e-05 | 199 | 146 | 9 | PS50853 | |
| Domain | ADAM_spacer1 | 2.83e-05 | 23 | 146 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.83e-05 | 23 | 146 | 4 | PF05986 | |
| Domain | IG_LIKE | NPHS1 LRFN1 CADM4 ICAM1 ICAM3 OBSCN OBSL1 PAPLN SEMA3G DSCAML1 NTM MYBPHL BCAM MERTK | 3.17e-05 | 491 | 146 | 14 | PS50835 |
| Domain | FN3_dom | 3.99e-05 | 209 | 146 | 9 | IPR003961 | |
| Domain | Ig-like_dom | NPHS1 LRFN1 CADM4 ICAM1 ICAM3 OBSCN OBSL1 PAPLN SEMA3G DSCAML1 NTM MYBPHL BCAM MERTK | 4.13e-05 | 503 | 146 | 14 | IPR007110 |
| Domain | Hydrolase_3 | 5.39e-05 | 10 | 146 | 3 | PF08282 | |
| Domain | P-loop_NTPase | MYO1G MYO1A KIF1A KIF26A NOA1 RNF213 RHOT2 MSH2 LRGUK EEF2 RUVBL1 STARD9 HELZ2 SEPTIN1 DHX35 KIFC3 POLQ KIF22 | 1.13e-04 | 848 | 146 | 18 | IPR027417 |
| Domain | TSP_1 | 1.33e-04 | 63 | 146 | 5 | PF00090 | |
| Domain | TSP1 | 1.54e-04 | 65 | 146 | 5 | SM00209 | |
| Domain | TSP1_rpt | 1.54e-04 | 65 | 146 | 5 | IPR000884 | |
| Domain | TSP1 | 1.54e-04 | 65 | 146 | 5 | PS50092 | |
| Domain | PLAC | 1.60e-04 | 14 | 146 | 3 | PF08686 | |
| Domain | AA_permease_N | 1.81e-04 | 3 | 146 | 2 | IPR013612 | |
| Domain | P-type_ATPase_IIA | 1.81e-04 | 3 | 146 | 2 | IPR005782 | |
| Domain | AA_permease_N | 1.81e-04 | 3 | 146 | 2 | PF08403 | |
| Domain | EGF-like_CS | 2.17e-04 | 261 | 146 | 9 | IPR013032 | |
| Domain | EGF_2 | 2.42e-04 | 265 | 146 | 9 | PS01186 | |
| Domain | Kinesin_motor_CS | 2.90e-04 | 41 | 146 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 3.49e-04 | 43 | 146 | 4 | IPR027640 | |
| Domain | ICAM | 3.60e-04 | 4 | 146 | 2 | IPR003988 | |
| Domain | PSI | 3.82e-04 | 44 | 146 | 4 | IPR016201 | |
| Domain | PSI | 4.53e-04 | 46 | 146 | 4 | SM00423 | |
| Domain | EGF | 5.30e-04 | 235 | 146 | 8 | SM00181 | |
| Domain | SRCR | 5.61e-04 | 21 | 146 | 3 | PF00530 | |
| Domain | ICAM_N | 5.98e-04 | 5 | 146 | 2 | PF03921 | |
| Domain | ICAM_N | 5.98e-04 | 5 | 146 | 2 | IPR013768 | |
| Domain | Peptidase_M12B_ADAM-TS | 8.40e-04 | 24 | 146 | 3 | IPR013273 | |
| Domain | ICAM_VCAM_N | 8.92e-04 | 6 | 146 | 2 | IPR003987 | |
| Domain | EGF_1 | 9.03e-04 | 255 | 146 | 8 | PS00022 | |
| Domain | - | 9.49e-04 | 25 | 146 | 3 | 3.10.250.10 | |
| Domain | SR | 9.49e-04 | 25 | 146 | 3 | SM00202 | |
| Domain | SRCR-like_dom | 1.07e-03 | 26 | 146 | 3 | IPR017448 | |
| Domain | SRCR_1 | 1.07e-03 | 26 | 146 | 3 | PS00420 | |
| Domain | SRCR_2 | 1.07e-03 | 26 | 146 | 3 | PS50287 | |
| Domain | Laminin_G | 1.10e-03 | 58 | 146 | 4 | IPR001791 | |
| Domain | SRCR | 1.19e-03 | 27 | 146 | 3 | IPR001190 | |
| Domain | Hirudin/antistatin | 1.24e-03 | 7 | 146 | 2 | IPR011061 | |
| Domain | SLC12A_fam | 1.24e-03 | 7 | 146 | 2 | IPR004842 | |
| Domain | Myosin_TH1 | 1.24e-03 | 7 | 146 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 1.24e-03 | 7 | 146 | 2 | IPR010926 | |
| Domain | TH1 | 1.24e-03 | 7 | 146 | 2 | PS51757 | |
| Domain | EGF_LAM_2 | 1.63e-03 | 30 | 146 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.63e-03 | 30 | 146 | 3 | PS01248 | |
| Domain | SLC12_C | 1.65e-03 | 8 | 146 | 2 | IPR018491 | |
| Domain | SLC12 | 1.65e-03 | 8 | 146 | 2 | PF03522 | |
| Domain | - | 1.97e-03 | 32 | 146 | 3 | 3.40.1110.10 | |
| Domain | Plexin_repeat | 1.97e-03 | 32 | 146 | 3 | IPR002165 | |
| Domain | - | 1.97e-03 | 32 | 146 | 3 | 2.70.150.10 | |
| Domain | PSI | 1.97e-03 | 32 | 146 | 3 | PF01437 | |
| Domain | PSI_integrin | 2.11e-03 | 9 | 146 | 2 | PF17205 | |
| Domain | Integin_beta_N | 2.11e-03 | 9 | 146 | 2 | IPR033760 | |
| Domain | EGF_Lam | 2.55e-03 | 35 | 146 | 3 | SM00180 | |
| Domain | ATPase_P-typ_cyto_domN | 2.55e-03 | 35 | 146 | 3 | IPR023299 | |
| Domain | Laminin_EGF | 2.55e-03 | 35 | 146 | 3 | PF00053 | |
| Domain | ATPase_P-typ_P_site | 2.77e-03 | 36 | 146 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 2.77e-03 | 36 | 146 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.77e-03 | 36 | 146 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.99e-03 | 37 | 146 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.99e-03 | 37 | 146 | 3 | PF00122 | |
| Domain | LAM_G_DOMAIN | 3.23e-03 | 38 | 146 | 3 | PS50025 | |
| Domain | Laminin_EGF | 3.23e-03 | 38 | 146 | 3 | IPR002049 | |
| Domain | EGF-like_dom | 3.48e-03 | 249 | 146 | 7 | IPR000742 | |
| Domain | Laminin_G_2 | 3.74e-03 | 40 | 146 | 3 | PF02210 | |
| Domain | EGF_dom | 3.80e-03 | 12 | 146 | 2 | IPR024731 | |
| Domain | EGF_3 | 3.80e-03 | 12 | 146 | 2 | PF12947 | |
| Domain | C2-set_2 | 4.01e-03 | 41 | 146 | 3 | PF08205 | |
| Domain | CD80_C2-set | 4.01e-03 | 41 | 146 | 3 | IPR013162 | |
| Domain | Ig_V-set | 4.80e-03 | 199 | 146 | 6 | IPR013106 | |
| Domain | LamG | 4.90e-03 | 44 | 146 | 3 | SM00282 | |
| Domain | ARM-type_fold | 5.25e-03 | 339 | 146 | 8 | IPR016024 | |
| Domain | - | 6.58e-03 | 95 | 146 | 4 | 2.60.120.200 | |
| Domain | ATPase_P-typ_TM_dom | 6.78e-03 | 16 | 146 | 2 | IPR023298 | |
| Domain | - | 6.78e-03 | 16 | 146 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 7.64e-03 | 17 | 146 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 7.64e-03 | 17 | 146 | 2 | PF00689 | |
| Domain | PP2C | 7.64e-03 | 17 | 146 | 2 | IPR015655 | |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | 1.75e-05 | 69 | 112 | 6 | M27150 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 1.21e-04 | 61 | 112 | 5 | M27581 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.28e-04 | 98 | 112 | 6 | M27152 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.03e-04 | 68 | 112 | 5 | M27303 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.17e-04 | 69 | 112 | 5 | M27108 | |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | 2.48e-04 | 71 | 112 | 5 | M1078 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 2.48e-04 | 71 | 112 | 5 | M27203 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.51e-04 | 39 | 112 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.51e-04 | 39 | 112 | 4 | MM15165 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 3.06e-04 | 115 | 112 | 6 | M19752 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 4.33e-04 | 80 | 112 | 5 | M6121 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 4.85e-04 | 82 | 112 | 5 | M27110 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 6.04e-04 | 86 | 112 | 5 | M601 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 6.04e-04 | 86 | 112 | 5 | M27206 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 6.37e-04 | 87 | 112 | 5 | M27205 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 6.73e-04 | 22 | 112 | 3 | M39440 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 6.92e-04 | 134 | 112 | 6 | M29840 | |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | 7.48e-04 | 136 | 112 | 6 | M27207 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 7.70e-04 | 23 | 112 | 3 | MM15885 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 7.96e-04 | 190 | 112 | 7 | M8240 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | IGKV1-17 IGKV1-16 IGKV1-12 HECTD3 KIF26A CTSC ICAM1 ICAM3 RNF213 TRIP12 PPP2R5B KLHL9 DCTN6 IGKV1D-16 IGKV1D-12 KIF22 | 8.22e-04 | 828 | 112 | 16 | M1058 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 9.00e-04 | 194 | 112 | 7 | M16312 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 9.50e-04 | 95 | 112 | 5 | M29842 | |
| Pathway | REACTOME_HEMOSTASIS | IGKV1-17 IGKV1-16 IGKV1-12 KIF1A KIF26A GRB7 PPP2R5B AKAP10 MERTK IGKV1D-16 IGKV1D-12 ATP2A1 ATP2A3 KIF22 | 9.60e-04 | 679 | 112 | 14 | M8395 |
| Pubmed | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-17 IGKV1D-13 | 1.40e-16 | 20 | 163 | 9 | 10427970 | |
| Pubmed | 8.02e-13 | 9 | 163 | 6 | 6777049 | ||
| Pubmed | IGKV1-27 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1D-13 IGKV1D-12 | 1.33e-12 | 18 | 163 | 7 | 20399194 | |
| Pubmed | 7.44e-11 | 16 | 163 | 6 | 17124007 | ||
| Pubmed | 9.60e-10 | 11 | 163 | 5 | 6795447 | ||
| Pubmed | Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis. | 9.60e-10 | 11 | 163 | 5 | 279004 | |
| Pubmed | Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes. | 9.60e-10 | 11 | 163 | 5 | 6767723 | |
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 6086934 | ||
| Pubmed | 1.26e-08 | 17 | 163 | 5 | 8223863 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 LRFN1 KIF26A OBSCN PAPLN PFAS RELB FAM110A RHOT2 IGF2R CELSR2 MEGF8 INTS11 TMEM268 HELZ2 PRKDC KIFC3 BCAM PC ATP2A3 SMAD7 | 5.86e-08 | 1105 | 163 | 21 | 35748872 |
| Pubmed | 7.13e-07 | 36 | 163 | 5 | 11298326 | ||
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 1.74e-06 | 77 | 163 | 6 | 15608191 | |
| Pubmed | 9.46e-06 | 156 | 163 | 7 | 37108203 | ||
| Pubmed | ACOT8 PPM1E RNF213 PFAS MSH2 ME1 PPP1R3D PPP2R5B IGF2R SLC12A2 INTS11 TAB1 SSH2 PC PPP6R2 NEURL4 KIF22 | 9.63e-06 | 1049 | 163 | 17 | 27880917 | |
| Pubmed | 1.21e-05 | 162 | 163 | 7 | 25826454 | ||
| Pubmed | COL6A2 ERF ARHGAP23 HECTD3 NOA1 OBSL1 GRB7 PAPLN PFAS FHIP2A RCC2 ARMC5 PPP6R2 | 1.31e-05 | 650 | 163 | 13 | 38777146 | |
| Pubmed | USP34 ACOT8 ERF ARHGAP23 HECTD3 CECR2 FAT3 OBSL1 RNF213 RHOT2 FAU VPS52 ZNF608 FAM120C INTS11 CSMD1 TLCD3A | 2.12e-05 | 1116 | 163 | 17 | 31753913 | |
| Pubmed | Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. | 2.18e-05 | 2 | 163 | 2 | 17537921 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11124526 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19225705 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24637679 | ||
| Pubmed | RelB promotes the migration and invasion of prostate cancer DU145 cells via exosomal ICAM1 in vitro. | 2.18e-05 | 2 | 163 | 2 | 34933092 | |
| Pubmed | Functional and non-functional joining in immunoglobulin light chain genes of a mouse myeloma. | 2.18e-05 | 2 | 163 | 2 | 6776411 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8325334 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22404936 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8372513 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 9539703 | ||
| Pubmed | PPM1E OBSL1 DDN FHIP2A KANK1 MEGF8 STARD9 ZFR2 SPHKAP PLXNB3 | 2.43e-05 | 407 | 163 | 10 | 12693553 | |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 2.72e-05 | 37 | 163 | 4 | 11416179 | |
| Pubmed | 2.82e-05 | 75 | 163 | 5 | 20637190 | ||
| Pubmed | 3.09e-05 | 257 | 163 | 8 | 16335952 | ||
| Pubmed | 4.61e-05 | 272 | 163 | 8 | 31010829 | ||
| Pubmed | 6.32e-05 | 144 | 163 | 6 | 35681168 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 7586691 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 17913807 | ||
| Pubmed | Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. | 6.53e-05 | 3 | 163 | 2 | 20133654 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 11585736 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 15572059 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 27989621 | ||
| Pubmed | Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. | 6.53e-05 | 3 | 163 | 2 | 10097137 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 11120869 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 31098411 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 16520097 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 16410239 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 24474251 | ||
| Pubmed | Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin. | 6.53e-05 | 3 | 163 | 2 | 20489725 | |
| Pubmed | USP34 GPRASP1 KIF1A OBSL1 TRIP12 DSCAML1 ITGB8 TXNDC11 EEF2 DCTN6 RNF10 DHX35 PRKDC KIFC3 MERTK PC PLXNB3 | 1.20e-04 | 1285 | 163 | 17 | 35914814 | |
| Pubmed | 1.23e-04 | 102 | 163 | 5 | 11214970 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 6264318 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 1448173 | ||
| Pubmed | Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7. | 1.30e-04 | 4 | 163 | 2 | 31852888 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 21972418 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 9705328 | ||
| Pubmed | Strength training with blood flow restriction diminishes myostatin gene expression. | 1.30e-04 | 4 | 163 | 2 | 21900845 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 3927006 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 26147384 | ||
| Pubmed | Genetic mapping of opioid binding protein gene(s) to mouse chromosome 9. | 1.30e-04 | 4 | 163 | 2 | 8439730 | |
| Pubmed | Inhibition of BMP2-induced, TAK1 kinase-mediated neurite outgrowth by Smad6 and Smad7. | 1.30e-04 | 4 | 163 | 2 | 11737269 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 25110346 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 15958383 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 6402305 | ||
| Pubmed | The nongastric H+-K+-ATPases: molecular and functional properties. | 1.30e-04 | 4 | 163 | 2 | 10362770 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 12600815 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 30049704 | ||
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 2.15e-04 | 25 | 163 | 3 | 9275178 | |
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 2175917 | ||
| Pubmed | Mismatch-repair protein MSH6 is associated with Ku70 and regulates DNA double-strand break repair. | 2.16e-04 | 5 | 163 | 2 | 21075794 | |
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 9834083 | ||
| Pubmed | The cytosolic protein talin induces an intermediate affinity integrin alphaLbeta2. | 2.16e-04 | 5 | 163 | 2 | 17591777 | |
| Pubmed | A hydride transfer complex reprograms NAD metabolism and bypasses senescence. | 2.16e-04 | 5 | 163 | 2 | 34547241 | |
| Pubmed | 2.16e-04 | 5 | 163 | 2 | 29758265 | ||
| Pubmed | Planar cell polarity pathway regulates nephrin endocytosis in developing podocytes. | 2.16e-04 | 5 | 163 | 2 | 23824190 | |
| Pubmed | Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. | 2.16e-04 | 5 | 163 | 2 | 10227978 | |
| Pubmed | 2.33e-04 | 117 | 163 | 5 | 17145500 | ||
| Pubmed | COX20 ACOT8 CTSC ICAM1 OBSL1 ECH1 GPKOW TRIP12 SHC3 EEF2 RUVBL1 FAM120C STARD9 INTS11 HELZ2 PC MUC5AC | 2.57e-04 | 1371 | 163 | 17 | 36244648 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 2.83e-04 | 67 | 163 | 4 | 21875946 | |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 3.04e-04 | 28 | 163 | 3 | 20309963 | |
| Pubmed | NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB. | 3.23e-04 | 6 | 163 | 2 | 24892805 | |
| Pubmed | 3.23e-04 | 6 | 163 | 2 | 11857637 | ||
| Pubmed | 3.23e-04 | 6 | 163 | 2 | 20065038 | ||
| Pubmed | 3.23e-04 | 6 | 163 | 2 | 12589052 | ||
| Pubmed | 3.23e-04 | 6 | 163 | 2 | 8672126 | ||
| Pubmed | 3.38e-04 | 29 | 163 | 3 | 20371770 | ||
| Pubmed | 3.38e-04 | 29 | 163 | 3 | 15071553 | ||
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 3.93e-04 | 73 | 163 | 4 | 32347575 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ERF RELB FHIP2A GPKOW PPP1R3D WDR91 VPS52 RUVBL1 RNF10 DHX35 TAB1 SSH2 SNAPC3 PPP6R2 | 4.02e-04 | 1038 | 163 | 14 | 26673895 |
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 4.13e-04 | 31 | 163 | 3 | 26095369 | |
| Pubmed | Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1. | 4.51e-04 | 7 | 163 | 2 | 24786561 | |
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 4.51e-04 | 7 | 163 | 2 | 18276594 | |
| Pubmed | Capturing novel mouse genes encoding chromosomal and other nuclear proteins. | 4.51e-04 | 7 | 163 | 2 | 9701556 | |
| Pubmed | Roles of pathway-specific and inhibitory Smads in activin receptor signaling. | 4.51e-04 | 7 | 163 | 2 | 9892009 | |
| Pubmed | 4.51e-04 | 7 | 163 | 2 | 12082081 | ||
| Pubmed | 4.51e-04 | 7 | 163 | 2 | 12444928 | ||
| Pubmed | 4.51e-04 | 7 | 163 | 2 | 21931564 | ||
| Pubmed | 4.97e-04 | 33 | 163 | 3 | 36522157 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | IGKV1-27 IGKV1-17 IGKV1-16 OBSCN ME1 TRIP12 SEPTIN1 IGKV1D-16 ATP2A3 | 5.94e-04 | 497 | 163 | 9 | 36774506 |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 6.00e-04 | 8 | 163 | 2 | 21613606 | |
| Pubmed | 6.00e-04 | 8 | 163 | 2 | 10951186 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 6.00e-04 | 8 | 163 | 2 | 19033399 | |
| Pubmed | 6.00e-04 | 8 | 163 | 2 | 27180624 | ||
| Interaction | LYPD4 interactions | 4.75e-06 | 123 | 154 | 8 | int:LYPD4 | |
| Cytoband | 2p12 | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 9.60e-18 | 117 | 163 | 14 | 2p12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.57e-14 | 213 | 163 | 14 | chr2p11 |
| Cytoband | 19p13.3-p13.2 | 1.55e-05 | 14 | 163 | 3 | 19p13.3-p13.2 | |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 2.09e-16 | 83 | 118 | 14 | 351 |
| GeneFamily | Immunoglobulin like domain containing | 4.90e-06 | 193 | 118 | 9 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 1.01e-05 | 160 | 118 | 8 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.06e-05 | 161 | 118 | 8 | 593 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.20e-05 | 46 | 118 | 5 | 622 | |
| GeneFamily | ADAMTS like | 8.68e-04 | 7 | 118 | 2 | 947 | |
| GeneFamily | Myosins, class I | 1.15e-03 | 8 | 118 | 2 | 1097 | |
| GeneFamily | ATPases Ca2+ transporting | 1.48e-03 | 9 | 118 | 2 | 1209 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.25e-03 | 40 | 118 | 3 | 592 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.23e-15 | 176 | 163 | 14 | d895a6b295cd649273ff80ad7785a3e0ae4c728a |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.23e-15 | 176 | 163 | 14 | 4b4416f342b732d2cc60133838728880326257d8 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.65e-14 | 194 | 163 | 14 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.77e-14 | 195 | 163 | 14 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.17e-13 | 177 | 163 | 13 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.17e-13 | 177 | 163 | 13 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.17e-13 | 177 | 163 | 13 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.35e-13 | 179 | 163 | 13 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.35e-13 | 179 | 163 | 13 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.35e-13 | 179 | 163 | 13 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-27 IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 2.21e-13 | 186 | 163 | 13 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 BCAS4 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.63e-13 | 197 | 163 | 13 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-17 IGKV1-9 IGKV1-8 IGKV1-6 EML6 SEMA3G TXNDC11 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 5.57e-12 | 188 | 163 | 12 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 6.31e-12 | 190 | 163 | 12 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 6.31e-12 | 190 | 163 | 12 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 7.59e-12 | 193 | 163 | 12 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-17 IGKV1D-16 IGKV1D-13 | 9.09e-12 | 196 | 163 | 12 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 TKTL2 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 1.48e-10 | 193 | 163 | 11 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-8 IGKV1-6 SLC12A3 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 1.65e-10 | 195 | 163 | 11 | df009b18898c10686f75cf72b4ec0eff18f5bb50 |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1D-17 IGKV1D-16 IGKV1D-13 | 1.01e-09 | 175 | 163 | 10 | d73ee324479172501481b54967a0f3bd870fcf3a |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | IGKV1-37 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.07e-09 | 176 | 163 | 10 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-17 IGKV1D-13 | 1.40e-09 | 181 | 163 | 10 | e47664a264a2c37390d1668ce04eef2e0172f4cb |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 ICAM3 TXNDC11 IGKV1D-16 | 1.64e-09 | 184 | 163 | 10 | 15f2c10101ccc8ed059520fc082ee42593dff269 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 ICAM3 TXNDC11 IGKV1D-16 | 1.64e-09 | 184 | 163 | 10 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 3.02e-09 | 196 | 163 | 10 | fec21383435779bf4c632decd3d29c6ca7baebfb |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-37 | 7.69e-09 | 159 | 163 | 9 | 204e5a675f4684c9570c24c8d34bbf632fd8164a |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 ICAM3 IGKV1D-13 IGKV1D-12 | 1.86e-08 | 176 | 163 | 9 | 50e207403d48ce1b55a78897adb5519a2430a626 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 ICAM3 IGKV1D-17 | 2.26e-08 | 180 | 163 | 9 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-17 IGKV1D-13 | 2.87e-08 | 185 | 163 | 9 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-17 IGKV1D-13 | 2.87e-08 | 185 | 163 | 9 | 0fff2608f507e019ebb69c27e58fd5be3b049bef |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | IGKV1-17 IGKV1-13 IGKV1-12 KANK1 ZNF608 MERTK POLQ IGKV1D-17 IGKV1D-12 | 3.00e-08 | 186 | 163 | 9 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-08 | 188 | 163 | 9 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-08 | 188 | 163 | 9 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-9 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-16 IGKV1D-13 | 3.45e-08 | 189 | 163 | 9 | 5a42be62552d912d0abf68f00d75ac80bbd69f2c |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-17 IGKV1D-16 IGKV1D-13 | 3.78e-08 | 191 | 163 | 9 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 TKTL2 IGKV1D-17 IGKV1D-12 | 4.32e-08 | 194 | 163 | 9 | a4a70369541876e1192df8828b63e3d1746ae3d9 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.72e-08 | 196 | 163 | 9 | c38e7f533c619afe008de0e99042f7180c2da918 |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-07 | 168 | 163 | 8 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|metastatic_Brain / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-6 ICAM3 IGKV1D-17 | 2.22e-07 | 170 | 163 | 8 | 53634da9e9c72f6400639954c286c6e38ea5a188 |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.74e-07 | 182 | 163 | 8 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 TXNDC11 IGKV1D-13 IGKV1D-12 | 4.06e-07 | 184 | 163 | 8 | 6f70d8f8ab8362d51f8a58735d42223e06566397 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-16 IGKV1-12 IGKV1-8 IGKV1-6 SLC12A3 IGKV1D-37 IGKV1D-16 IGKV1D-13 | 6.31e-07 | 195 | 163 | 8 | 13f4ee21568fd747608412d33559d10561dbb3c8 |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | IGKV1-37 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-16 IGKV1D-13 | 6.31e-07 | 195 | 163 | 8 | d0305c6a68c9e361507b04db94f86873085d49b3 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-07 | 196 | 163 | 8 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 6.81e-07 | 197 | 163 | 8 | 2662138671262b30508c5759038bcdcfe6551696 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-07 | 200 | 163 | 8 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 7.64e-07 | 200 | 163 | 8 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-9 IGKV1-8 IGKV1-6 SLC12A3 IGKV1D-13 IGKV1D-12 | 2.29e-06 | 162 | 163 | 7 | b46158e260bd2f35702cec73e3b035e8e9ec4469 |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-13 IGKV1D-12 | 2.29e-06 | 162 | 163 | 7 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 IGKV1D-13 IGKV1D-12 | 2.29e-06 | 162 | 163 | 7 | f945688815229c8386cbcbf46deee7df316fa8d3 |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-16 | 2.92e-06 | 168 | 163 | 7 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-06 | 169 | 163 | 7 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-06 | 169 | 163 | 7 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-06 | 170 | 163 | 7 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-06 | 170 | 163 | 7 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.15e-06 | 170 | 163 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-06 | 170 | 163 | 7 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-06 | 173 | 163 | 7 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | IGKV1-37 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-16 | 4.11e-06 | 177 | 163 | 7 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-8 IGKV1-6 TXNDC11 IGKV1D-12 | 4.77e-06 | 181 | 163 | 7 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 181 | 163 | 7 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-06 | 182 | 163 | 7 | 1bf2e4fd6222b41a7d08df6dcc500c9401db8c18 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 5.12e-06 | 183 | 163 | 7 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | IGKV1-17 IGKV1-13 IGKV1-9 TXNDC11 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 5.12e-06 | 183 | 163 | 7 | a6866951866373a1029e04818f4a4a31278c409d |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 5.12e-06 | 183 | 163 | 7 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-17 | 5.12e-06 | 183 | 163 | 7 | cf5c98f451a568308c52da5c926543dd4836c6b2 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-17 IGKV1-12 IGKV1-8 TXNDC11 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 5.50e-06 | 185 | 163 | 7 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-17 IGKV1-12 IGKV1-8 TXNDC11 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 5.50e-06 | 185 | 163 | 7 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | COVID-19-lung-Plasmablasts|lung / Disease (COVID-19 only), tissue and cell type | 5.70e-06 | 186 | 163 | 7 | 81caf67da9fed09c77b7ddcab9b0b8e4fab2de97 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 186 | 163 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | COVID-19-lung-Plasmablasts|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.33e-06 | 189 | 163 | 7 | fdf6c945b352614885e646a5ef4bc576dee73895 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 190 | 163 | 7 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-06 | 190 | 163 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-12 IGKV1-9 ICAM3 IGKV1D-17 IGKV1D-16 IGKV1D-13 | 6.78e-06 | 191 | 163 | 7 | da4062a0f6d0af6d330acf11da216c64b0fa7c73 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 191 | 163 | 7 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-06 | 192 | 163 | 7 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-06 | 194 | 163 | 7 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-06 | 194 | 163 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-6 IGKV1D-17 IGKV1D-13 | 7.51e-06 | 194 | 163 | 7 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-06 | 194 | 163 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-9 IGKV1-8 IGKV1-6 IGKV1D-13 | 7.76e-06 | 195 | 163 | 7 | 600174e35574fe7c44dd923adcf43686e7b01e39 |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-06 | 196 | 163 | 7 | 34e79918a448f6c19b87e1b1ce13c012b24be1f8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-06 | 196 | 163 | 7 | 8f82e01ca50aa4cd6149547505b4474a02fad618 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.30e-06 | 197 | 163 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-8 TXNDC11 IGKV1D-13 | 8.30e-06 | 197 | 163 | 7 | b754fad4f3caae6de95df901fd96ea8697fe41b1 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.86e-06 | 199 | 163 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 8.86e-06 | 199 | 163 | 7 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.40e-05 | 142 | 163 | 6 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma-Plasma_cells|blood / Manually curated celltypes from each tissue | 1.71e-05 | 147 | 163 | 6 | 58089378fac1743ce99dc4f1bd7b5253a927f050 | |
| ToppCell | 10x5'-blood-Myeloid_Mac-Intermediate_macrophages|blood / Manually curated celltypes from each tissue | 1.78e-05 | 148 | 163 | 6 | b801f38d249a02c4ceceb242cabbbc88418e5fd1 | |
| ToppCell | 10x5'-blood-Myeloid_Mac|blood / Manually curated celltypes from each tissue | 1.78e-05 | 148 | 163 | 6 | 1ae2d7475e030e2de49940f3287b02953dbf3c65 | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma|blood / Manually curated celltypes from each tissue | 1.92e-05 | 150 | 163 | 6 | 6bab0a8bf78ed7de9e1b67ede7496488f80f4863 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-05 | 154 | 163 | 6 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 2.66e-05 | 159 | 163 | 6 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | COVID-19_Moderate-MAIT|World / disease group, cell group and cell class | 2.76e-05 | 160 | 163 | 6 | bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-05 | 164 | 163 | 6 | cf62d34ce9dd220fe61748466c84fd70d9ba697c | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-05 | 164 | 163 | 6 | e00549bc8b3a5566f39031f39d7e698b0b107a7f | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 167 | 163 | 6 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 167 | 163 | 6 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 3.51e-05 | 167 | 163 | 6 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| Disease | COMM domain-containing protein 1 measurement | 2.67e-05 | 2 | 153 | 2 | EFO_0802424 | |
| Disease | level of nuclear factor NF-kappa-B p105 subunit in blood serum | 2.67e-05 | 2 | 153 | 2 | OBA_2040323 | |
| Disease | Brody myopathy (implicated_via_orthology) | 7.99e-05 | 3 | 153 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | non-Hodgkin lymphoma (is_marker_for) | 7.99e-05 | 3 | 153 | 2 | DOID:0060060 (is_marker_for) | |
| Disease | remnant cholesterol measurement | 2.55e-04 | 108 | 153 | 5 | EFO_0010815 | |
| Disease | ICAM-1 measurement | 2.55e-04 | 24 | 153 | 3 | EFO_0004520 | |
| Disease | kallikrein-7 measurement | 2.64e-04 | 5 | 153 | 2 | EFO_0008195 | |
| Disease | free cholesterol measurement | 3.14e-04 | 113 | 153 | 5 | EFO_0008591 | |
| Disease | X-12112 measurement | 3.95e-04 | 6 | 153 | 2 | EFO_0800705 | |
| Disease | glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement | 5.51e-04 | 7 | 153 | 2 | EFO_0800520 | |
| Disease | N2,N2-dimethylguanosine measurement | 7.33e-04 | 8 | 153 | 2 | EFO_0021125 | |
| Disease | semaphorin-3G measurement | 7.33e-04 | 8 | 153 | 2 | EFO_0802049 | |
| Disease | interleukin 1 receptor-like 2 measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0008169 | |
| Disease | glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 9.39e-04 | 9 | 153 | 2 | EFO_0800476 | |
| Disease | vitamin B6 measurement | 1.17e-03 | 10 | 153 | 2 | EFO_0004621 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.48e-03 | 94 | 153 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.70e-03 | 12 | 153 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | pneumonia | 1.88e-03 | 47 | 153 | 3 | EFO_0003106 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 1.88e-03 | 47 | 153 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | pancreatic cancer (is_marker_for) | 1.92e-03 | 101 | 153 | 4 | DOID:1793 (is_marker_for) | |
| Disease | intercellular adhesion molecule 5 measurement | 2.01e-03 | 13 | 153 | 2 | EFO_0008164 | |
| Disease | phospholipids in medium LDL measurement | 2.11e-03 | 49 | 153 | 3 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 2.11e-03 | 49 | 153 | 3 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 2.11e-03 | 49 | 153 | 3 | EFO_0022227 | |
| Disease | familial hyperlipidemia | 2.29e-03 | 106 | 153 | 4 | MONDO_0001336 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.33e-03 | 14 | 153 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | total lipids in medium LDL | 2.51e-03 | 52 | 153 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 2.51e-03 | 52 | 153 | 3 | EFO_0022308 | |
| Disease | N,N,N-trimethyl-5-aminovalerate measurement | 2.68e-03 | 15 | 153 | 2 | EFO_0800090 | |
| Disease | lipoprotein A measurement | 2.80e-03 | 112 | 153 | 4 | EFO_0006925 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 2.98e-03 | 114 | 153 | 4 | EFO_0004574, EFO_0004611 | |
| Disease | total lipids in large LDL | 3.26e-03 | 57 | 153 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 3.26e-03 | 57 | 153 | 3 | EFO_0021901 | |
| Disease | keratinocyte carcinoma | 3.37e-03 | 118 | 153 | 4 | EFO_0010176 | |
| Disease | phospholipids in small LDL measurement | 3.59e-03 | 59 | 153 | 3 | EFO_0022297 | |
| Disease | free cholesterol in VLDL measurement | 3.95e-03 | 61 | 153 | 3 | EFO_0022276 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.21e-03 | 291 | 153 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 4.26e-03 | 126 | 153 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | Obesity | 4.40e-03 | 205 | 153 | 5 | C0028754 | |
| Disease | esterified cholesterol measurement | 4.51e-03 | 128 | 153 | 4 | EFO_0008589 | |
| Disease | interstitial lung disease | 5.14e-03 | 67 | 153 | 3 | EFO_0004244 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALNELVECVGSTRGV | 106 | Q15173 | |
| GVLAVTCAQEGVIRV | 296 | O14734 | |
| RARGGVCIADEVQTG | 311 | Q9BYV1 | |
| LIGSTTSRCEVQDRG | 146 | P04003 | |
| VVARRLGRGSVSDCS | 176 | P50548 | |
| EAVEGGVRCRSRSIQ | 476 | P43681 | |
| AECGTGIQRRSVVCL | 856 | Q6UY14 | |
| ILVGSSRRVCQADGT | 3186 | Q96PZ7 | |
| FHVEVASRGRECVSG | 11 | Q8NHY0 | |
| REGELEGACRTVSDV | 631 | Q96BT7 | |
| VVRLEIESNICREGG | 456 | O43572 | |
| GSELVERGQRCGVEV | 231 | P33121 | |
| AEARLSAGCVGERIT | 466 | P27037 | |
| EASCITIERVIGAGE | 671 | P54756 | |
| RVVVCGESVGGAAVA | 186 | Q5VUY2 | |
| TEGACRTEVRRLGGI | 141 | Q96C12 | |
| GEDCREAVQRLGVSA | 61 | Q9GZQ3 | |
| EGSIINRIEAVCVGD | 141 | Q8TF64 | |
| VVTVDGCDTGVALRF | 1481 | Q9HCU4 | |
| TCEDRIRVRGGDTEC | 1241 | Q9NR16 | |
| IRVRGGDTECSGRVE | 1246 | Q9NR16 | |
| LSRGEGVFVIDATCV | 446 | O94850 | |
| AQGCVRDLSTVADRG | 1056 | Q9BXF3 | |
| EVTGSIQLCRDAGIR | 606 | O14983 | |
| VIERCSSVRVGSRTA | 521 | Q93084 | |
| TAVAICRRLGIFGDT | 631 | Q93084 | |
| LRGCTIRNTEAVVGI | 276 | Q9P241 | |
| CGGGERRTIVSCTRI | 816 | Q8TE56 | |
| DRLGCRITATAGAAV | 166 | P36021 | |
| AGVRVRTVVSGSCAA | 146 | Q9P258 | |
| DCGGLREVEVTACLV | 171 | Q01201 | |
| VCLEVETGRVGAAGA | 1466 | O75147 | |
| LTVVEGASVELRCGV | 41 | O60500 | |
| DVREIGTIIRSLGCC | 171 | Q5VUJ9 | |
| VLRGAETEGCVIVSA | 1586 | Q14667 | |
| ASVVCRELGFGSARE | 341 | P58215 | |
| VALGVVACGLRQITD | 461 | P48163 | |
| GACLTQGLAEVARVR | 11 | Q8WWB3 | |
| DTGSGRIALAVEICA | 1641 | Q16787 | |
| SVGDRVTITCRASQG | 36 | P01611 | |
| EVCGSVAAVEERLRG | 491 | O43187 | |
| VSEVSNGTSRRAGCV | 316 | Q9P121 | |
| TCTVRIAAVTRGGVG | 456 | Q12866 | |
| AGQDVGRSCILVSIA | 11 | Q5TA45 | |
| RDRDQCILITGESGS | 91 | Q9UBC5 | |
| VVEGQAVSLRCRAVG | 311 | Q9P244 | |
| SVGDRVTITCRVSQG | 36 | P0DSN7 | |
| SVGDRVTITCRASQG | 36 | A0A0B4J2D9 | |
| RQGVCETRRLGDVAE | 136 | Q9ULL4 | |
| CGVDRTITRGGCVAQ | 86 | Q8NGV0 | |
| GSLITAGRIDREELC | 86 | Q9Y5H3 | |
| ASGDLVIREDCRGNI | 191 | Q14807 | |
| ISRDADCRAVVISGA | 96 | Q13011 | |
| GGCSRRSSVTVEERA | 246 | Q9BQ89 | |
| RIRADGVVDCARGQS | 61 | O95750 | |
| RECGGRALLTNVSSV | 1261 | Q7Z7M0 | |
| ELRENGECRSVAVGA | 391 | Q14678 | |
| ISGVSLDNCVEVGRI | 146 | Q9P2J3 | |
| SVGDRVTITCRARQG | 36 | A0A075B6S4 | |
| TCVCRTDEGRVLEGL | 391 | Q92917 | |
| GTRFSVRVSAVEVCG | 511 | Q9ULI4 | |
| CEETLVFIETGTARG | 61 | Q6UWN0 | |
| DTVEGIARDGLASCI | 496 | Q96M69 | |
| ISARCGANGTIERRV | 1301 | P98088 | |
| GCCVSDLISRTVGRV | 106 | Q9Y693 | |
| GACRSVEVAAGATAR | 111 | Q14451 | |
| VAAEECGSVVEPGRR | 21 | Q9NY74 | |
| EIVCNVTLGGERREA | 291 | P32942 | |
| AARESLRCGTTGVVT | 321 | Q8WY54 | |
| GDLRGRVARCDSSIV | 211 | Q96LP2 | |
| VREGSEATFRCRVGG | 121 | Q5VST9 | |
| GGSRSERCDIVSNLI | 76 | P26012 | |
| GLRDCIATGIQSVRD | 41 | Q6ICH7 | |
| TCGEGTEVRQVLCRA | 981 | O15072 | |
| GVVIVVLASRAGARC | 276 | A4D1S0 | |
| RRSCDVGVGGFILVT | 56 | Q5RI15 | |
| AVAGRDTLINCRVIG | 516 | Q8TD84 | |
| VAAVTVAGRVAEERG | 111 | Q9H5Z1 | |
| RSCLQRREGEEVTGS | 516 | O75417 | |
| ALCDRDVTVTAIGIG | 746 | P12110 | |
| GRERVSLVELCDGQA | 866 | Q9NX05 | |
| DGGGRTTFCTVRVIV | 2576 | Q8TDW7 | |
| VRRVDVGCLDNRGSV | 731 | Q2V2M9 | |
| IRRGTDECAIESIAV | 441 | P53634 | |
| NVTVAEGGVAEITCR | 31 | Q8NFZ8 | |
| VAGITEVTCTGARDV | 191 | Q8TDM0 | |
| GCALDTRRVSVRNGE | 91 | A2RUH7 | |
| EDTRQLGLVVCRGTS | 66 | Q9UK45 | |
| AVDAVGRSCTGTLVV | 551 | Q08554 | |
| GSVQRVEILEGRTEC | 191 | P19235 | |
| SVGDRVTITCRASQG | 36 | A0A0C4DH72 | |
| GDRVTITCRASQGIS | 36 | A0A0C4DH67 | |
| SVGDRVTITCRASQG | 36 | A0A0C4DH69 | |
| SVGDRVTITCRASQG | 36 | A0A0C4DH73 | |
| SVGDRVTITCRASQG | 36 | P0DP09 | |
| SVGDRVTITCRASQG | 36 | P04430 | |
| SVGDRVTITCRASQG | 36 | P01599 | |
| SVGDRVTITCRASQG | 36 | A0A075B6S5 | |
| SVGDRVTITCRVSQG | 36 | A0A075B6S9 | |
| EDEGTQRLTCAVILG | 281 | P05362 | |
| CKAGIIASARAGETR | 41 | P13639 | |
| ETGQLVECVRSVCRG | 1641 | Q6ZMW3 | |
| GCRSLFSVIVRVVGD | 686 | Q5W0V3 | |
| VAVTRAQEGLCLIGD | 2596 | Q9BYK8 | |
| VVRAGAAGTAEATAR | 126 | P50895 | |
| LRLVDGVTECSGRLE | 266 | Q86VB7 | |
| GVTECSGRLEVRFQG | 271 | Q86VB7 | |
| RCAGTVEVEIQRLLG | 381 | Q86VB7 | |
| VVCVESEIRGDVTIG | 16 | O00399 | |
| EVSIVDCILARVGAG | 701 | P43246 | |
| VGCDRLLSEAQRITG | 291 | Q9UHL4 | |
| SGCSVLRDGRSVLEE | 131 | Q96JN8 | |
| RTAEADGGLARTVCQ | 166 | Q8NC60 | |
| PTVARTEEAVGRVGC | 856 | O75170 | |
| TEEAVGRVGCADSRL | 861 | O75170 | |
| CVFRSDSRGGSEAVV | 541 | Q12756 | |
| GAREETIRREAGSCS | 816 | Q5JY77 | |
| CRRTTTGDVQVLGLV | 2046 | P11717 | |
| RCCDVTIIRIGTSGG | 136 | O95045 | |
| SAVAVCGLGEREEVT | 566 | Q2M3C7 | |
| VGIICGQESTRRIGD | 231 | Q15750 | |
| TVVCRNVAGGVREDR | 231 | Q8IXI1 | |
| GTGVVRSCRTAVELY | 456 | Q5TEA6 | |
| LIVTVRGVDCSTGLR | 651 | Q9BVG8 | |
| GECLGNVVSDERRVS | 146 | Q9UK23 | |
| TREAISRVCEAVPGA | 181 | Q92529 | |
| GREVTASCRLTQGAV | 551 | Q9P2P6 | |
| RDSIRCVSDLQIGGE | 216 | Q92966 | |
| ILEVTAGRTTGGDIC | 186 | O75570 | |
| EEACILRGGALSTVR | 51 | Q86T13 | |
| AVVGSCEVVRDGGNR | 231 | Q8WYJ6 | |
| RHRVLLGVTDTVEGC | 176 | Q5VZI3 | |
| NDRLCVGIVASERAG | 1981 | Q63HN8 | |
| GTAACADVRGVLDRL | 216 | Q8N1B4 | |
| LLQAVESRGGTRTAC | 111 | O15105 | |
| GDAVRRVLECVATGT | 831 | Q9UPR6 | |
| SVDLALGNETGRCVV | 686 | Q7Z392 | |
| GGRNESCRLSVVEVA | 681 | Q76I76 | |
| EGDTARLLCVVAGES | 1146 | O95428 | |
| CVQGVVLEDGTEVRS | 321 | Q8N2H3 | |
| ECGLVVGDRVIDVGS | 36 | Q00403 | |
| VALCALGRRVTAGFE | 646 | A6NE52 | |
| CCRIVEARGLESTGI | 926 | Q9P227 | |
| IRDVQCTGRGAHVVA | 331 | O15067 | |
| ACFVGTITGDRRIVL | 586 | O15067 | |
| AGSRREVTGVVAALE | 386 | Q8N5U6 | |
| VALGCATRGRTIAFA | 376 | Q9H0I9 | |
| ATGSGIVIIRSCDDV | 51 | Q8TBR7 | |
| IAVSVGSCVVRDATG | 536 | P55011 | |
| QCGVEALTTLEVVGR | 81 | A6NDN8 | |
| RVTCSDLGISGTVRV | 181 | O95685 | |
| ATIGSCVVRDASGVL | 391 | P55017 | |
| LREGQSRCDGRVEVS | 436 | Q4G0T1 | |
| AGVFCSESVALRLRG | 651 | Q4G0T1 | |
| SNRGNCVIRGTEDIT | 331 | Q9Y265 | |
| ARRGSCVTQVGLLES | 1786 | P78527 | |
| CRTISRGVSGFIDSE | 536 | Q6PKC3 | |
| RTRSVGVNTCEVGVV | 346 | Q9ULD9 | |
| VCQTLEDGRRRSVGL | 31 | Q9BSN7 | |
| VTVSRVGRVCVNDAG | 261 | Q9NS98 | |
| QCGVEALTTLEVAGR | 56 | P62861 | |
| TSVEDIGGRSCVTRF | 2406 | Q70CQ2 | |
| CTVTCAGGIRERTRV | 506 | P35442 | |
| EGASVVATCAVREGT | 161 | P0DP72 | |
| FCVGVAGRARVSVEV | 11 | Q6GMV2 | |
| GGAECLVEIRSIVSE | 1136 | Q14669 | |
| VDCSGRRVASLDVDG | 416 | A4D1P6 | |
| VAERGAVGTSLEGRC | 26 | Q9H091 | |
| AVGTSLEGRCRQLEA | 31 | Q9H091 | |
| GEIAIRVFRACTELG | 46 | P11498 | |
| IELRRGACVRTTGEE | 96 | Q5T447 | |
| SVGDRVTITCRASQG | 36 | P01601 | |
| QGEGRTLEVRVSDCI | 966 | B0I1T2 |